Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Gui-Qi Zhu, Min Sun, Wei-Ting Liao, Wei-Hua Yu, Shao-Lai Zhou, Zheng-Jun Zhou, Ying-Hong Shi, Jia Fan, Jian Zhou, Li-Xin Qiu & Zhi Dai. (2018) Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 12:9, pages 935-945.
Read now
Read now
Maria Pleguezuelo, Giacomo Germani, Laura Marelli, Elias Xiruochakis, Maria Misseri, Pinelopi Manousou, Vasiliki Arvaniti & Andrew K Burroughs. (2008) Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2:6, pages 761-784.
Read now
Read now
Teh-Ia Huo, Yi-Hsiang Huang, Jen-Huei Chiang, Jaw-Ching Wu, Pui-Ching Lee, Chin-Wen Chi & Shou-Dong Lee. (2007) Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?. Scandinavian Journal of Gastroenterology 42:4, pages 485-492.
Read now
Read now
T.‐I. Huo, Y.‐H. Huang, J.‐C. Wu, P.‐C. Lee, F.‐Y. Chang & S.‐D. Lee. (2004) Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. Scandinavian Journal of Gastroenterology 39:2, pages 168-173.
Read now
Read now
T.‐I. Huo, J.‐C. Wu, W.‐Y. Lui, R.‐C. Lee, C.‐C. Loong, Y.‐H. Huang, S.‐H. Tsay, F.‐Y. Chang & S.‐D. Lee. (2004) Reliability of contemporary radiology to measure tumour size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications. Scandinavian Journal of Gastroenterology 39:1, pages 46-52.
Read now
Read now
John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell & Geoffrey W McCaughan. (2003) Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 4:12, pages 2175-2185.
Read now
Read now
Articles from other publishers (59)
Qaed Salem Alhammami, Sultan Nawi Arfaj Alanazi, Sultan Mudhhi H Alanazi, Ahmed Rashed Elnoor Mohammed, Sulaiman Turki Arfaj Alanazi & Zainab Ayesh Alruwaily. (2023) Role of Interventional Radiology in Management of Hepatocellular Carcinoma: Systematic Review. Archives of Pharmacy Practice 14:1, pages 16-22.
Crossref
Crossref
Sivesh K. Kamarajah, James R. Bundred, Peter Littler, Helen Reeves, Derek M. Manas & Steven A. White. (2021) Treatment strategies for early stage hepatocellular carcinoma: a systematic review and network meta-analysis of randomised clinical trials. HPB 23:4, pages 495-505.
Crossref
Crossref
Rani J Qasem, Ibrahim K Frah, Ahmad S Aljada & Faisal A Sehli. (2021) Bioanalysis of plasma acetate levels without derivatization by LC–MS/MS. Bioanalysis 13:5, pages 373-386.
Crossref
Crossref
Samuel A. Einstein, Emily A. Thompson, Chunxiao Guo, Elizabeth M. Whitley, James A. Bankson & Erik N.K. Cressman. (2020) Application of Trifluoroacetic Acid as a Theranostic Agent for Chemical Ablation of Solid Tissue. Journal of Vascular and Interventional Radiology 31:1, pages 169-175.
Crossref
Crossref
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher & Valérie Vilgrain. (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 69:1, pages 182-236.
Crossref
Crossref
Davide Roccarina, Avik Majumdar, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis & Kurinchi Selvan Gurusamy. (2017) Management of people with intermediate-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
David J. Breen & Riccardo Lencioni. (2015) Image-guided ablation of primary liver and renal tumours. Nature Reviews Clinical Oncology 12:3, pages 175-186.
Crossref
Crossref
Sebastian Weis, Annegret Franke, Thomas Berg, Joachim Mössner, Wolfgang E. Fleig & Konrad Schoppmeyer. (2015) Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2019:2.
Crossref
Crossref
Paul D. Hansen, Maria A. Cassera & Ronald F. Wolf. (2015) Ablative Technologies for Hepatocellular, Cholangiocarcinoma, and Metastatic Colorectal Cancer of the Liver. Surgical Oncology Clinics of North America 24:1, pages 97-119.
Crossref
Crossref
Ashish Kumar, Subrat K. Acharya, Shivaram P. Singh, Vivek A. Saraswat, Anil Arora, Ajay Duseja, Mahesh K. Goenka, Deepali Jain, Premashish Kar, Manoj Kumar, Vinay Kumaran, Kunisshery M. Mohandas, Dipanjan Panda, Shashi B. Paul, Jeyamani Ramachandran, Hariharan Ramesh, Padaki N. Rao, Samir R. Shah, Hanish Sharma & Ragesh B. Thandassery. (2014) The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. Journal of Clinical and Experimental Hepatology 4, pages S3-S26.
Crossref
Crossref
Ragesh B. Thandassery, Usha Goenka & Mahesh K. Goenka. (2014) Role of Local Ablative Therapy for Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 4, pages S104-S111.
Crossref
Crossref
Nahum Méndez-Sánchez, Ezequiel Ridruejo, Angelo Alves de Mattos, Norberto C. Chávez-Tapia, Rodrigo Zapata, Raymundo Paraná, Ricardo Mastai, Edna Strauss, Luis Gonzalo Guevara-Casallas, Jorge Daruich, Adrian Gadano, Edison Roberto Parise, Misael Uribe, Nancy E. Aguilar-Olivos, Lucy Dagher, Ben-Hur Ferraz-Neto, Martha Valdés-Sánchez & Juan F. Sánchez-Avila. (2014) Latin American Association for the Study of the Liver (LAASL) Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Annals of Hepatology 13, pages S4-S40.
Crossref
Crossref
Andrea Mancuso. (2013) Management of hepatocellular carcinoma: Enlightening the gray zones. World Journal of Hepatology 5:6, pages 302.
Crossref
Crossref
Hossein Ghanaati, Seyed Moayed Alavian, Ali Jafarian, Nasser Ebrahimi Daryani, Mohsen Nassiri-Toosi, Amir Hossein Jalali & Madjid Shakiba. (2012) Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. Iranian Journal of Radiology 9:4, pages 167-77.
Crossref
Crossref
. (2012) EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 56:4, pages 908-943.
Crossref
Crossref
. (2012) EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. European Journal of Cancer 48:5, pages 599-641.
Crossref
Crossref
Sandro Rossi, Giorgia Ghittoni & Valentina Ravetta. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
1376
1388.e3
.
Massimo Colombo & Massimo Iavarone. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
650
660
.
Riccardo Lencioni. (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:2, pages 762-773.
Crossref
Crossref
Giacomo Germani, Maria Pleguezuelo, Kurinchi Gurusamy, Tim Meyer, Graziella Isgrò & Andrew Kenneth Burroughs. (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. Journal of Hepatology 52:3, pages 380-388.
Crossref
Crossref
Michael A. Heneghan & Andrew D. Yeoman. 2010. Malignant Liver Tumors. Malignant Liver Tumors
266
280
.
Konrad Schoppmeyer, Sebastian Weis, Joachim Mössner & Wolfgang E. Fleig. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Michael B. Wallace & Luis Carlos Sabbagh. (2009) EUS 2008 Working Group document: evaluation of EUS-guided tumor ablation. Gastrointestinal Endoscopy 69:2, pages S59-S63.
Crossref
Crossref
Yun Ku Cho, Jae Kyun Kim, Mi Young Kim, Hyunchul Rhim & Joon Koo Han. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:2, pages 453-459.
Crossref
Crossref
D S CHO, H S AHN, S I KIM, Y S KIM, S J KIM, G S JEON & J H WON. (2008) Sclerotherapy of renal cysts using acetic acid: a comparison with ethanol sclerotherapy. The British Journal of Radiology 81:972, pages 946-949.
Crossref
Crossref
Chien‐Hung Chen, Chi‐Sin Changchien, Chuan‐Mo Lee, Chao‐Hung Hung, Tsung‐Hui Hu, Jing‐Houng Wang, Jyh‐Chwan Wang & Sheng‐Nan Lu. (2008) Combined Mutations in Pre‐S/Surface and Core Promoter/Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma: A Case-Control Study. The Journal of Infectious Diseases 198:11, pages 1634-1642.
Crossref
Crossref
Riccardo Lencioni, Laura Crocetti, Clotilde Della Pina & Dania Cioni. 2010. Interventional Oncology. Interventional Oncology
145
159
.
W.-L. TSAI, J.-S. CHENG, K.-H. LAI, C.-P. LIN, G.-H. LO, P.-I. HSU, H.-C. YU, C.-K. LIN, H.-H. CHAN, W.-C. CHEN, T.-A. CHEN, W.-L. LI & H.-L. LIANG. (2008) Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - a long-term follow-up study. Alimentary Pharmacology & Therapeutics 28:3, pages 304-311.
Crossref
Crossref
Teh-Ia Huo, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Jen-Huei Chiang, Yi-You Chiou, Samantha C. Huo, Pui-Ching Lee & Shou-Dong Lee. (2008) Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy. Clinical Transplantation 22:4, pages 469-475.
Crossref
Crossref
Enrico M Zardi, Domenico Borzomati, Fabio Cacciapaglia, Antonio Picardi, Sergio Valeri, Antonella Bianchi, Tommaso Galeotti, Giusy Coppolino, Roberto Coppola & Antonella Afeltra. (2007) Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model. BMC Gastroenterology 7:1.
Crossref
Crossref
Robin D. Kim, Alan I. Reed, Shiro Fujita, David P. Foley, Kristin L. Mekeel & Alan W. Hemming. (2007) Consensus and Controversy in the Management of Hepatocellular Carcinoma. Journal of the American College of Surgeons 205:1, pages 108-123.
Crossref
Crossref
Sean Garrean, Justin Hering, W. Scott Helton & N. Joseph Espat. (2007) A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. The American Journal of Surgery 194:1, pages 79-88.
Crossref
Crossref
Eveline Boucher, Etienne Garin, Anne Guylligomarc’h, Damien Olivié, Karim Boudjema & Jean-Luc Raoul. (2007) Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma. Radiotherapy and Oncology 82:1, pages 76-82.
Crossref
Crossref
. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
1269
1297
.
H. C. Spangenberg. (2007) Lokal-ablative TherapieLocal ablative therapy. Der Gastroenterologe 2:1, pages 27-33.
Crossref
Crossref
H. Kühl. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
838
852
.
Giuseppe Garcea & David P. Berry. 2007. Regional Cancer Therapy. Regional Cancer Therapy
229
267
.
Teh-Ia Huo, Yi-Hsiang Huang, Hui-Chun Huang, Jaw-Ching Wu, Pui-Ching Lee, Full-Young Chang & Shou-Dong Lee. (2006) Fever and Infectious Complications After Percutaneous Acetic Acid Injection Therapy for Hepatocellular Carcinoma: Incidence and Risk Factor Analysis. Journal of Clinical Gastroenterology 40:7, pages 639-642.
Crossref
Crossref
Teh-Ia Huo, Pui-Ching Lee, Yi-Hsiang Huang, Jaw-Ching Wu, Han-Chieh Lin, Jen-Huei Chiang & Shou-Dong Lee. (2006) The Sequential Changes of the Model for End-stage Liver Disease Score Correlate With the Severity of Liver Cirrhosis in Patients With Hepatocellular Carcinoma Undergoing Locoregional Therapy. Journal of Clinical Gastroenterology 40:6, pages 543-550.
Crossref
Crossref
Teh-Ia Huo, Han-Chieh Lin, Yi-Hsiang Huang, Jaw-Ching Wu, Jen-Huei Chiang, Pui-Ching Lee & Shou-Dong Lee. (2006) The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 107:1, pages 141-148.
Crossref
Crossref
Teh-Ia Huo, Yi-Hsiang Huang, Han-Chieh Lin, Jaw-Ching Wu, Jen-Huei Chiang, Pui-Ching Lee, Full-Young Chang & Shou-Dong Lee. (2006) Proposal of a Modified Cancer of the Liver Italian Program Staging System Based on the Model for End-Stage Liver Disease for Patients with Hepatocellular Carcinoma Undergoing Loco-Regional Therapy. The American Journal of Gastroenterology 101:5, pages 975-982.
Crossref
Crossref
Nathalie Ganne-Carrié, Virginie Williams, Halima Kaddouri, Jean-Claude Trinchet, Samira Dziri-Mendil, Chakib Alloui, Nasser Al Hawajri, Paul Dény, Michel Beaugrand & Emmanuel Gordien. (2006) Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint Denis District of Paris (France). Journal of Medical Virology 78:3, pages 335-340.
Crossref
Crossref
Andrew Hines-Peralta, Zheng-jun Liu, Clare Horkan, Stephanie Solazzo & S. Nahum Goldberg. (2006) Chemical Tumor Ablation with Use of a Novel Multiple-tine Infusion System in a Canine Sarcoma Model. Journal of Vascular and Interventional Radiology 17:2, pages 351-358.
Crossref
Crossref
M. Golling, A. Schaudt & W. O. Bechstein. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
937
957
.
W. Dempke, K. Alimi & M. Gebel. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
882
892
.
Riccardo Lencioni, Clodilde Della Pina, Laura Crocetti & Dania Cioni. 2006. Minimally Invasive Tumor Therapies. Minimally Invasive Tumor Therapies
91
105
.
Aaron Shields & K. Rajender Reddy. (2005) Hepatocellular carcinoma: Current treatment strategies. Current Treatment Options in Gastroenterology 8:6, pages 457-466.
Crossref
Crossref
Teh-Ia Huo, Jaw-Ching Wu, Han-Chieh Lin, Fa-Yauh Lee, Ming-Chih Hou, Pui-Ching Lee, Full-Young Chang & Shou-Dong Lee. (2005) Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh score. Journal of Hepatology 42:6, pages 826-832.
Crossref
Crossref
Riccardo Lencioni & Laura Crocetti. (2005) A Critical Appraisal of the Literature on Local Ablative Therapies for Hepatocellular Carcinoma. Clinics in Liver Disease 9:2, pages 301-314.
Crossref
Crossref
Teh-Ia Huo, Yi-Hsiang Huang & Jaw-Ching Wu. (2005) Percutaneous Ablation Therapy for Hepatocellular Carcinoma: Current Practice and Future Perspectives. Journal of the Chinese Medical Association 68:4, pages 155-159.
Crossref
Crossref
Yung-Chang LinJeon-Hor ChenKun-Wan HanWu-Chung Shen. (2005) Ablation of Liver Tumor by Injection of Hypertonic Saline. American Journal of Roentgenology 184:1, pages 212-219.
Crossref
Crossref
TEH-IA HUO & SHOU-DONG LEE. (2004) Management of inoperable hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 19:s7, pages S272-S278.
Crossref
Crossref
Teh-Ia Huo, Jaw-Ching Wu, Han-Chieh Lin, Fa-Yauh Lee, Ming-Chih Hou, Yi-Hsiang Huang, Pui-Ching Lee, Full-Young Chang & Shou-Dong Lee. (2004) Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transplantation 10:12, pages 1507-1513.
Crossref
Crossref
Teh-Ia Huo, Jaw-Ching Wu, Wing-Yiu Lui, Yi-Hsiang Huang, Pui-Ching Lee, Jen-Huei Chiang, Full-Young Chang & Shou-Dong Lee. (2004) Differential Mechanism and Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma Undergoing Surgical and Nonsurgical Treatment. The American Journal of Gastroenterology 99:8, pages 1479-1487.
Crossref
Crossref
Teh-Ia Huo, Jaw-Ching Wu, Cheng-Yuan Hsia, Gar-Yang Chau, Wing-Yiu Lui, Yi-Hsiang Huang, Pui-Ching Lee, Full-Young Chang & Shou-Dong Lee. (2004) Hepatitis C Virus Infection is a Risk Factor for Tumor Recurrence after Resection of Small Hepatocellular Carcinomas. World Journal of Surgery 28:8, pages 787-791.
Crossref
Crossref
T. Huo, Y.-H. Huang, J.-C. Wu, J.-H. Chiang, P.-C. Lee, F.-Y. Chang & S.-D. Lee. (2004) Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. Alimentary Pharmacology & Therapeutics 19:12, pages 1301-1308.
Crossref
Crossref
T.-I. Huo, Y.-H. Huang, J.-C. Wu, P.-C. Lee, F.-Y. Chang & S.-D. Lee. (2004) Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. Annals of Oncology 15:5, pages 775-780.
Crossref
Crossref
Helene Norder, Anne-Marie Couroucé, Pierre Coursaget, José M. Echevarria, Shou-Dong Lee, Isa K. Mushahwar, Betty H. Robertson, Stephen Locarnini & Lars O. Magnius. (2004) Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HB<sub>s</sub>Ag Subtypes. Intervirology 47:6, pages 289-309.
Crossref
Crossref
T.-I. Huo, Y.-H. Huang, J.-C. Wu, J.-H. Chiang, P.-C. Lee, F.-Y. Chang & S.-D. Lee. (2003) Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Annals of Oncology 14:11, pages 1648-1653.
Crossref
Crossref